XPEL, Inc. (XPEL)

On our desk, XPEL's Q2 2026 print was a solid beat with revenues landing at $143.1 million—about 5.9% ahead of consensus. EPS also surprised to the upside at $0.65. However, roughly $2 million of this top-line beat came from pull-ahead sales ahead of Q3 price hikes. While the top-line momentum is undeniable, the valuation feels quite demanding given the near-term margin pressure from their $110 million manufacturing push. I am maintaining a neutral stance until we see cleaner cash flow generation.

From a risk management standpoint, XPEL's aggressive pivot toward vertical integration through manufacturing asset acquisitions in China and Texas introduces significant operational complexity. Transitioning away from a contract manufacturing model lowers third-party costs long-term, but it loads up the balance sheet with heavy capital expenditures and new supply chain compliance risks. We are tracking execution closely before sizing up long exposure.

Analyzing the channel breakdown for XPEL reveals a clear divergence: the U.S. independent channel is outperforming dramatically, offsetting persistent headwinds in the dealership channel, softer European markets, and down regions like India and the Middle East. For anyone evaluating their growth sustainability, monitoring independent installation attach rates versus OEM headwinds is the primary diagnostic metric.

As an equity analyst covering specialty auto parts, XPEL's recent performance underscores its pricing power—evidenced by the proactive Q3 price increases that triggered pre-buy behavior. International expansion, particularly in China and Asia-Pacific, continues to offset localized weakness. The key question for the next 12 to 18 months is how cleanly management can execute the transition to direct production without disrupting distribution quality.

As a hedge fund PM, I view XPEL as an exceptional niche compounder in the automotive aftermarket, especially with 51% of sales tied to the aftermarket providing insulation from broader auto cycle weakness. Management's long-term target of hitting mid-20% operating margins by 2028 via in-house production is ambitious. Yet, with the stock trading at a premium valuation and net income constrained by growth investments, we prefer to wait for a better entry point.